Abstract
Among type 2 diabetes (T2D) patients, oral medications are called oral hypoglycaemic agents (OHAs), which are preferred over injections due to convenience and acceptability. These are a group of drugs that have been used successfully worldwide for controlling T2D patients to reduce the high blood sugar. These can be classified as either hypoglycaemic agents, such as sulfonylureas and benzoic acid derivatives or antihyperglycaemic agents, such as Biguanides, α-glucosidase inhibitors, and Thiazolidinediones. Most of these stimulate β-cells of the Islets of Langerhans within the pancreas to produce insulin. These should be taken at about the same time every day according to the advices of physician. The most common side-effects of OHAs are hypoglycaemia and weight gain.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
